Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Hypoport SE

Start price
Target price
Perf. (%)
€86.20
16.10.22
€90.00
16.10.23
-4.58%
17.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Mag Silver Corp.

Start price
Target price
Perf. (%)
€17.26
30.10.21
-
18.01.25
-25.35%
17.10.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
buy
Altamir Amboise

Start price
Target price
Perf. (%)
€23.86
16.10.21
€28.00
16.10.22
-1.78%
17.10.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
buy
Hypoport SE

Start price
Target price
Perf. (%)
€88.85
11.10.22
€90.00
11.10.23
-2.98%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
08.10.22
€5.00
08.10.23
9.28%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.12
04.09.22
-
04.09.23
-11.64%
15.10.22

Could be worthwhile Investment >10% per year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-15.38%
15.10.22

Risky Investment
buy
Nordex SE

Start price
Target price
Perf. (%)
€16.12
07.03.22
€19.00
07.03.23
-48.60%
15.10.22

Could be worthwhile Investment >10% per year
buy
Nordex SE

Start price
Target price
Perf. (%)
€16.12
07.03.22
€19.00
07.03.23
-48.60%
15.10.22

Could be worthwhile Investment >10% per year
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€56.70
12.10.21
-
12.10.22
14.20%
13.10.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€56.70
12.10.21
-
12.10.22
14.20%
13.10.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€56.40
12.10.21
-
12.10.22
10.82%
12.10.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€56.40
12.10.21
-
12.10.22
10.82%
12.10.22

buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€36.16
11.10.21
€50.00
11.10.22
14.49%
12.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Renesas Electronics Corp.

Start price
Target price
Perf. (%)
€10.10
10.10.21
€12.00
10.10.22
-14.57%
11.10.22

Could be worthwhile Investment >10% per year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.10
10.10.21
€15.00
10.10.22
-84.33%
11.10.22

Could be worthwhile Investment >10% per year
Some uniques
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
buy
Exel Industries A

Start price
Target price
Perf. (%)
€71.20
09.10.21
€78.00
09.10.22
-44.38%
10.10.22

Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.38
03.10.22
€7.00
03.10.23
-44.51%
06.10.22

Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.76
30.09.22
-
30.09.23
39.41%
03.10.22

Risky Investment
buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€1.75
03.08.22
€2.00
03.08.23
-24.43%
03.10.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year